TransMedics Group Inc (TMDX)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit margin | 59.31% | 59.29% | 60.66% | 62.37% | 63.77% | 66.14% | 69.05% | 68.78% | 69.84% | 71.85% | 72.34% | 72.79% | 69.92% | 67.33% | 67.68% | 65.92% | 64.88% | 64.60% | 60.89% | 61.04% |
| Operating profit margin | 8.49% | 7.84% | -0.22% | -4.79% | -11.89% | -19.87% | -10.14% | -20.28% | -33.64% | -50.15% | -81.97% | -108.19% | -130.29% | -120.46% | -89.78% | -98.86% | -102.91% | -121.24% | -131.56% | -119.65% |
| Pretax margin | 8.10% | 8.14% | 0.41% | -3.92% | -11.04% | -19.41% | -11.72% | -23.70% | -38.70% | -58.70% | -92.66% | -119.78% | -145.99% | -134.05% | -100.05% | -110.43% | -112.00% | -131.21% | -143.78% | -134.04% |
| Net profit margin | 8.03% | 8.14% | 0.84% | -3.43% | -10.36% | -18.65% | -11.77% | -23.76% | -38.77% | -58.78% | -92.76% | -119.88% | -146.11% | -134.15% | -100.14% | -110.54% | -112.13% | -131.35% | -143.93% | -134.19% |
TransMedics Group Inc's profitability ratios have shown mixed performance over the analyzed periods. The gross profit margin has generally improved, indicating that the company has been able to control its production costs and generate higher profits from its core operations. However, the operating profit margin has fluctuated significantly, starting from negative percentages but gradually moving towards positive territory by the end of the period. This suggests that the company has worked on efficiency improvements and cost-cutting measures to enhance its operational profitability.
The pretax margin and net profit margin also show a similar trend of improvement over time, moving from negative percentages to positive figures by the end of the period. This signals that TransMedics Group Inc has been successful in managing its overall expenses and generating higher profits after accounting for all costs, including taxes. Overall, the improving trend in profitability margins is a positive indication of the company's ability to enhance its financial performance and potentially increase shareholder value over time.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 4.66% | 4.00% | -0.11% | -1.96% | -4.07% | -5.53% | -2.22% | -8.41% | -11.34% | -13.09% | -35.95% | -34.10% | -29.23% | -25.92% | -19.13% | -17.06% | -17.35% | -18.32% | -19.50% | -32.66% |
| Return on assets (ROA) | 4.41% | 4.15% | 0.40% | -1.41% | -3.54% | -5.19% | -2.58% | -9.86% | -13.07% | -15.34% | -40.68% | -37.79% | -32.78% | -28.87% | -21.34% | -19.08% | -18.91% | -19.84% | -21.34% | -36.63% |
| Return on total capital | 17.24% | 17.30% | 4.77% | -1.21% | -11.57% | -22.97% | -8.49% | -12.75% | -17.41% | -20.55% | -86.33% | -71.67% | -59.40% | -43.24% | -29.33% | -24.46% | -23.80% | -25.11% | -26.88% | -66.75% |
| Return on equity (ROE) | 15.51% | 15.55% | 1.58% | -6.39% | -18.24% | -28.29% | -12.25% | -14.69% | -19.34% | -22.45% | -93.71% | -78.22% | -65.16% | -48.20% | -33.70% | -28.48% | -27.67% | -28.86% | -30.60% | -76.05% |
TransMedics Group Inc has shown a gradual improvement in its profitability ratios over the past few years. The Operating return on assets (Operating ROA) was negative in the initial periods but turned positive by the end of 2024, indicating better operational efficiency in generating profits from its assets. The Return on assets (ROA) also followed a similar trend, improving from negative values to positive figures by the end of 2024, showing that the company's overall profitability on its total assets has increased.
Additionally, the Return on total capital and Return on equity (ROE) ratios exhibited a similar pattern of improvement, transitioning from negative to positive values by the end of 2024. These ratios suggest that TransMedics Group Inc has been able to generate adequate returns for its capital providers and shareholders, reflecting enhanced financial performance and a better utilization of invested capital.
Overall, the positive trend in profitability ratios indicates an upward trajectory in TransMedics Group Inc's financial performance and suggests a more efficient and profitable operation going forward.